电子邮件 | bja***@***.com | 获取Email |
---|
电子邮件 | bja***@***.com | 获取Email |
---|
Kodiak is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC Platform™ uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies and is at the core of Kodiak's discovery engine. Kodiak's lead product candidate, tarcocimab tedromer, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including wet age-related macular degeneration, the leading cause of blindness in elderly patients in the developed world, and diabetic eye diseases, the leading cause of blindness in working-age patients in the developed world. Kodiak has leveraged its ABC Platform to build a pipeline of product candidates in various stages of development. KSI-501 is our dual inhibitor antibody biopolymer conjugate targeting both VEGF (VEGF-trap) and IL-6 (anti-IL-6 antibody) for the treatment of retinal diseases. We are expanding our early research pipeline to include ABC Platform based triplet inhibitors for multifactorial retinal diseases such as dry AMD and glaucoma. WORKING AT KODIAK We foster a culture of curiosity, creativity, compassion and courage. Our collective goal is to make a difference in the world. We do that as a team driven by the shared desire to tackle some of the world's biggest challenges. If this sounds exciting, we want to hear from you! Kodiak supports a vibrant and active lifestyle, striving to provide an optimal work-life balance. We are located in Palo Alto, in the heart of the world-class biotech hub of Silicon Valley, and within walking distance to California Avenue's shops, restaurants and public transportation.
公司 | Kodiak Sciences |
---|---|
职位 | VP Chemistry |
地点 | United States |
http://www.linkedin.com/in/bernd-jandeleit-65323219 | |
部门 | |
头衔 | VP Chemistry at Kodiak Sciences, Inc. |
Kodiak Sciences VP Chemistry
2020-07-01 -
Quadriga BioSciences, Inc. Co-Founder, VP of Chemistry
2010-10-01 - 2020-06-01
Founder and Managing Director
2010-05-01 - 2015-07-01
XenoPort, Inc. Associate Director, Medicinal Chemistry
2008-01-01 - 2010-05-01
XenoPort, Inc. Principal Investigator, Medicinal Chemistry
2004-06-01 - 2007-12-01
Bernd Jandeleit 在 Kodiak Sciences 担任 VP Chemistry at Kodiak Sciences, Inc.
Bernd Jandeleit 在 Kodiak Sciences 的职位是 VP Chemistry at Kodiak Sciences, Inc.
Bernd Jandeleit 的电子邮件地址是 bja***@***.com
Bernd Jandeleit 的电话号码是 -
Bernd Jandeleit 的公司电话号码是 +165****
Bernd Jandeleit 在 research 工作。
Bernd Jandeleit 的一些同事包括Daniel Vasquez、Kameron Kilchrist、Bernd Jandeleit、Fiona GeigerJoshua Condran、。
Bernd Jandeleit联系方式: 电子邮件地址:bja***@***.com 电话号码:-
Bernd Jandeleit 的个人领英是:http://www.linkedin.com/in/bernd-jandeleit-65323219
Bernd Jandeleit 的办公地点:1200 Page Mill Road, Palo Alto, California 94304, US
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd